[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 Notice for Phreesia, Inc. (PHR) shows a proposed sale of 114 common shares through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $2,654.42. The shares were acquired by the seller on 09/11/2025 upon restricted stock vesting and the consideration is listed as compensation. The filing reports the issuer has 59,914,473 shares outstanding. The document also lists multiple insider sales during the prior three months, including notable transactions by David Linetsky: 23,729 shares for $676,195.48 on 06/27/2025 and 17,445 shares for $518,681.81 on 08/22/2025. Other smaller sales by Jessica Weiss and additional sales by Linetsky are recorded with dates and gross proceeds. The filer certifies there is no undisclosed material adverse information known to the seller.

Insights

Securities Analyst

TL;DR: Routine insider sale filing disclosing restricted stock vesting and multiple recent insider dispositions; no new operational information disclosed.

The Form 144 documents a small planned sale of 114 vested shares valued at $2,654.42 and lists several recent insider dispositions, including two large sales by David Linetsky (23,729 shares for $676,195.48 and 17,445 shares for $518,681.81). This filing is procedural, intended to comply with Rule 144 disclosure requirements for sales by affiliates. It does not present earnings, operational changes, or new material facts about the issuer. For investors, the filing provides transparency on insider liquidity but does not itself indicate a change in company fundamentals.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing insiders exercising/disposing vested compensation; governance processes appear followed.

The notice identifies the nature of acquisition as restricted stock vesting and records the planned sale through a broker, satisfying procedural Rule 144 requirements. Multiple past sales by named insiders are disclosed with dates and gross proceeds, which supports transparency around insider transactions. The signer attests no undisclosed material adverse information exists. The filing contains standard legal cautions and does not reflect any governance action beyond routine insider liquidity and required reporting.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	114	2654.42	59914473	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			114	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/17/2025	42	1057.23
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/18/2025	67	1715.96
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/27/2025	23729	676195.48
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	2063	55465.41
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/18/2025	78	2274.13
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/22/2025	17445	518681.81

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)